tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
US Market

Adaptimmune Therapeutics (ADAP) Stock Investors

Compare
891 Followers
Based on 803,748 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ADAP
On average, investors allocate 2.23% of their portfolios to ADAP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 803,748 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ADAP

1.6%
Last 7
Days
5.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ADAP, out of 803,748 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ADAP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.11%
$0.29
Based on the activity of investors who made their portfolios public
The table shows changes in ADAP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ADAP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.68%
-0.68%
-1.81%
2.93B
Healthcare
JD
4.45%
-0.65%
-0.85%
52.01B
Consumer Cyclical
Block
3.46%
-0.69%
-2.10%
37.87B
Technology
DraftKings
4.26%
+1.53%
+6.55%
32.46B
Consumer Cyclical
Nio
7.78%
-0.81%
-0.98%
7.13B
Consumer Cyclical
Bristol-Myers Squibb
3.14%
-0.20%
-0.71%
101.25B
Healthcare
Delta Air Lines
4.46%
-0.40%
-0.76%
30.71B
Industrials
CVS Health
4.03%
-0.33%
-1.61%
85.34B
Healthcare
Riot Platforms
4.53%
-0.23%
-0.03%
3.47B
Financial
Abbott Laboratories
3.33%
-1.06%
-2.02%
235.96B
Healthcare
Based on the activity of 803,748 active portfolios
Open your Smart Portfolio

ADAP Investor Analysis

ADAP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.8%
of ADAP holders
are under 35
Average Segment Performance
Average P/E Ratio20.53
Beta4.60
Dividend Yield4.09%
ADAP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
55.8%
of ADAP holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.79
Beta11.42
Dividend Yield3.52%
ADAP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.4%
of ADAP holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta3.72
Dividend Yield3.81%
Overview of age group and performance of ADAP stock investors
See who invests in ADAP according to age group and performance.

FAQ

How many retail Investors hold ADAP?
<0.1% of TipRanks' retail investors hold ADAP in their portfolios.
    What is ADAP Investor Sentiment?
    ADAP’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ADAP in the last 7 days?
      ▼ 1.6% of TipRanks' retail investors changed their holding of ADAP in the last 7 days.
        What percentage of retail investors changed their holding of ADAP in the last 30 days?
        ▼ 5.8% of TipRanks' retail investors changed their holding of ADAP in the last 30 days.
          What is the average age of retail investors who hold ADAP?
          The average age of ADAP Holders is between 35–55.
            What other stocks have ADAP investors also bought?
            ADAP Investors also bought VKTX, JD, XYZ, DKNG, NIO, BMY, DAL, CVS, RIOT, ABT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis